Filing Details

Accession Number:
0001209191-22-045421
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-11 16:19:35
Reporting Period:
2022-08-11
Accepted Time:
2022-08-11 16:19:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805890 Fusion Pharmaceuticals Inc. FUSN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643085 Steven Gannon C/O Fusion Pharmaceuticals, Inc.
2 International Place, Suite 2310
Boston MA 02110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-11 44,400 $2.03 56,400 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct